Not applicableStudy completedNCT00914537What this trial is testingAnal Cancer Screening StudyWho this might be right forAnal Cancer National Cancer Institute (NCI) 363
Testing effectiveness (Phase 2)Looking for participantsNCT06088381What this trial is testingSelective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)Who this might be right forHead and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more University of Maryland, Baltimore 61
Testing effectiveness (Phase 2)Looking for participantsNCT05541016What this trial is testingDe-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNAWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+4 more Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT00325130What this trial is testingConcomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)Who this might be right forNeoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more Merck Sharp & Dohme LLC 1,042
Early research (Phase 1)Looking for participantsNCT07081984What this trial is testingStudy of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid TumorsWho this might be right forHPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer Therorna 12
Large-scale testing (Phase 3)Study completedNCT00337428What this trial is testingConcomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)Who this might be right forNeoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more Merck Sharp & Dohme LLC 843
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551What this trial is testingPhase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive CarcinomaWho this might be right forHPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more SCG Cell Therapy Pte. Ltd. 66
Not applicableNot Yet RecruitingNCT07523152What this trial is testingAssessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal StudyWho this might be right forPelvic CancerAnal CancerVaginal Cancer Institut du Cancer de Montpellier - Val d'Aurelle 42
Testing effectiveness (Phase 2)Looking for participantsNCT07209189What this trial is testingNeoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)Who this might be right forHead and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Testing effectiveness (Phase 2)Study completedNCT02513238What this trial is testingMesenchymal Stemcells for Radiation Induced XerostomiaWho this might be right forXerostomia Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178301What this trial is testingEvaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT TrialWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Northwestern University 100
Testing effectiveness (Phase 2)Study completedNCT04180215What this trial is testingA Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other CancersWho this might be right forHPV-Related Squamous Cell Carcinoma Hookipa Biotech GmbH 198
Not applicableUnknownNCT03721484What this trial is testingCINtec PLUS Triage in HPV Primary ScreeningWho this might be right forCervical Cancer Western Health and Social Care Trust 9,800
Early research (Phase 1)WithdrawnNCT02686008What this trial is testingPharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCCWho this might be right forSquamous Cell Carcinoma of the Head and Neck Yale University
Testing effectiveness (Phase 2)Looking for participantsNCT04444869What this trial is testingTesting Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal CancerWho this might be right forCancer of the Head and NeckOropharynx CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more University of Missouri-Columbia 28
Testing effectiveness (Phase 2)Study completedNCT01807546What this trial is testingOral Rigosertib for Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more Traws Pharma, Inc. 64
Large-scale testing (Phase 3)Active Not RecruitingNCT05721755What this trial is testingCombining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forClinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+8 more ECOG-ACRIN Cancer Research Group
Large-scale testing (Phase 3)Active Not RecruitingNCT03952585What this trial is testingDe-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal CancerWho this might be right forBasaloid Squamous Cell CarcinomaClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03215719What this trial is testingAdaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal CarcinomaWho this might be right forOropharyngeal CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma NYU Langone Health 120
Early research (Phase 1)Study completedNCT02178072What this trial is testingWindow Trial 5-aza in HNSCC, T-tareWho this might be right forHead and Neck Squamous Cell Carcinoma Yale University 18